SPDR S&P Biotech ETF $XBI Shares Acquired by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 19,218 shares of the exchange traded fund’s stock after purchasing an additional 4,848 shares during the period. Kingswood Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,030,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Vertrix Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 5.0% during the 3rd quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock valued at $237,000 after buying an additional 71 shares during the last quarter. Compound Planning Inc. grew its stake in shares of SPDR S&P Biotech ETF by 0.7% during the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after acquiring an additional 75 shares during the period. PeakShares LLC raised its stake in SPDR S&P Biotech ETF by 5.2% in the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after acquiring an additional 84 shares during the period. Robertson Stephens Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 0.5% in the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock valued at $3,412,000 after acquiring an additional 99 shares during the period. Finally, Compass Ion Advisors LLC raised its stake in SPDR S&P Biotech ETF by 3.0% in the 3rd quarter. Compass Ion Advisors LLC now owns 3,993 shares of the exchange traded fund’s stock valued at $630,000 after acquiring an additional 117 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.6%

NYSEARCA XBI opened at $150.47 on Tuesday. The company has a market cap of $10.50 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The firm’s 50-day simple moving average is $157.13 and its two-hundred day simple moving average is $140.94.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.